For laboratory research use only. This page summarizes public scientific literature. It is not medical advice and does not describe or endorse human, clinical, or veterinary use.
Chemistry & identity
| CAS Number | 189691-06-3 |
|---|---|
| Molecular Formula | C50H68N14O10 |
| Molecular Weight | 1025.2 g/mol |
| Residue Count | 7 |
| PubChem CID | 9941379 |
Peptide sequence
XDHFRWK
Research context
Cyclic lactam Ac-Nle-Asp-His-D-Phe-Arg-Trp-Lys ((2->7)-lactam) per PubChem systematic name; X = Nle (norleucine), residue 4 is D-Phe.
Selected research references
Published peer-reviewed literature on PT-141 (Bremelanotide). Provided for research-context purposes only; CC Peptides does not make claims about outcomes in humans.
- Bremelanotide for the Treatment of Hypoactive Sexual Desire Disorder: Two Randomized Phase 3 Trials
- Safety Profile of Bremelanotide Across the Clinical Development Program
- Responder Analyses from a Phase 2b Dose-Ranging Study of Bremelanotide
- Bremelanotide for female sexual dysfunctions in premenopausal women: a randomized, placebo-controlled dose-finding trial
PT-141 (Bremelanotide) for laboratory research
CC Peptides supplies PT-141 (Bremelanotide) as a lyophilized reference material with a third-party COA. Ships from California.
View product page →